Avita Medical | 1811094D - 债务利息支出



金融业
股票价格
AUD
资产
AUD 56.39M
现金及等价物
AUD 10.24M
销售成本
AUD 3.3M
流动资产
AUD 35.49M
流动负债
AUD 62.68M
债务
AUD 46.05M
EBIT
AUD -10.39M
EBITDA
AUD -9.69M
员工
AUD 87
EPS每股收益
AUD -0.38
股本和储备
AUD -16.65M
销售毛利
AUD 14.31M
债务利息支出
AUD 1.25M
贷款资金
AUD 42.25M
市值
AUD 152.75M
净收入
AUD -11.62M
营业费用
AUD 28.02M
营业利润
AUD -10.41M
税前利润
AUD -11.64M
销售收入
AUD 17.62M
销售和管理费用
AUD 19.03M
股票
AUD 6.93M
贸易债权人
AUD 8.96M
应收帐款人
AUD 9.11M


债务利息支出 更改 日
Accuray USD 2.88M 72K 2024-12
Celltrion KRW 19B 1.96B 2025-06
Clinuvel Pharmaceuticals AUD 2.49M 51.97K 2025-06
Cochlear AUD 6.3M 3.65M 2025-12
CSL USD 215M 111M 2025-12
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-03
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Mayne Pharma AUD 1.2M 50K 2024-06
Medical Developments International AUD 18K 3K 2025-06
Nanosonics AUD 779K 94K 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-06
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Paradigm Biopharmaceuticals AUD 1000 3K 2025-06
Pharma Mar EUR 117K 1.24M 2025-09
Polynovo AUD 506K 130K 2025-06
PYC Therapeutics AUD 17K 11K 2025-06
Qiagen NV USD 10.14M 1.92M 2025-12
Ramsay Health Care AUD 300.6M 15.5M 2025-12
ResMed USD 775K 886K 2024-12
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Telix Pharmaceuticals AUD 7.62M 11.22M 2025-12
Tilray USD 6.7M 2.73M 2025-06
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06